2021 Q1 Form 10-Q Financial Statement

#000120677421001404 Filed on May 07, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $72.62M $76.71M
YoY Change -5.34% 17.64%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $880.0K $949.0K
YoY Change -7.27% 16.58%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $11.46M $21.43M
YoY Change -46.54% 5.81%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $43.87M $7.077M
YoY Change 519.9% -49.91%
Income Tax $10.87M $1.047M
% Of Pretax Income 24.78% 14.79%
Net Earnings $33.00M $6.030M
YoY Change 447.25% -48.17%
Net Earnings / Revenue 45.44% 7.86%
Basic Earnings Per Share $0.83 $0.15
Diluted Earnings Per Share $0.82 $0.15
COMMON SHARES
Basic Shares Outstanding 39.79M shares 39.70M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $260.1M $282.8M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $42.80M $59.80M
YoY Change -28.43% 68.45%
Goodwill $208.4M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $7.450B $7.279B
YoY Change 2.34% 20.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $15.30M $28.70M
YoY Change -46.69% 71.86%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $15.30M $28.70M
YoY Change -46.69% 71.86%
LONG-TERM LIABILITIES
Long-Term Debt $152.7M $129.0M
YoY Change 18.37% 0.31%
Other Long-Term Liabilities $35.00M $31.90M
YoY Change 9.72% 34.03%
Total Long-Term Liabilities $187.7M $160.9M
YoY Change 16.66% 5.58%
TOTAL LIABILITIES
Total Short-Term Liabilities $15.30M $28.70M
Total Long-Term Liabilities $187.7M $160.9M
Total Liabilities $6.514B $6.426B
YoY Change 1.38% 19.73%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $935.6M $853.7M
YoY Change
Total Liabilities & Shareholders Equity $7.450B $7.279B
YoY Change 2.34% 20.34%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income $33.00M $6.030M
YoY Change 447.25% -48.17%
Depreciation, Depletion And Amortization $880.0K $949.0K
YoY Change -7.27% 16.58%
Cash From Operating Activities $80.13M $46.46M
YoY Change 72.47% 257.42%
INVESTING ACTIVITIES
Capital Expenditures $67.00K $1.728M
YoY Change -96.12% 572.37%
Acquisitions
YoY Change
Other Investing Activities $5.700M -$93.60M
YoY Change -106.09% 166.67%
Cash From Investing Activities $5.622M -$95.36M
YoY Change -105.9% 169.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$129.4M $130.2M
YoY Change -199.38% 478.1%
NET CHANGE
Cash From Operating Activities $80.13M $46.46M
Cash From Investing Activities $5.622M -$95.36M
Cash From Financing Activities -$129.4M $130.2M
Net Change In Cash -$43.66M $81.33M
YoY Change -153.69% 44584.62%
FREE CASH FLOW
Cash From Operating Activities $80.13M $46.46M
Capital Expenditures $67.00K $1.728M
Free Cash Flow $80.06M $44.73M
YoY Change 78.98% 251.07%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
972000 USD
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
39773602 shares
CY2020Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
63637000 USD
CY2020Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
240119000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
536000 USD
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000712771
CY2021Q1 dei Entity Information Former Legal Or Registered Name
EntityInformationFormerLegalOrRegisteredName
N/A
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
972000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
536000 USD
CY2021Q1 cnob Issuance Date Preferred Securities
IssuanceDatePreferredSecurities
2003-12-19
CY2020 cnob Issuance Date Preferred Securities
IssuanceDatePreferredSecurities
2003-12-19
CY2021Q1 us-gaap Subordinated Borrowing Due Date
SubordinatedBorrowingDueDate
2034-01-23
CY2020 us-gaap Subordinated Borrowing Due Date
SubordinatedBorrowingDueDate
2034-01-23
CY2021Q1 cnob Redeemable By Issuer Beginning Date
RedeemableByIssuerBeginningDate
2009-01-23
CY2020 cnob Redeemable By Issuer Beginning Date
RedeemableByIssuerBeginningDate
2009-01-23
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
303756000 USD
CY2020Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
487955000 USD
CY2020Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
13387000 USD
CY2020Q4 us-gaap Loans Receivable Held For Sale Amount
LoansReceivableHeldForSaleAmount
4710000 USD
CY2020Q4 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
6236307000 USD
CY2020Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
79226000 USD
CY2020Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
6157081000 USD
CY2020Q4 us-gaap Investment Owned Restricted Cost
InvestmentOwnedRestrictedCost
25099000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
331951000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30108000 USD
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2658633 shares
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
30271000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2797000 USD
CY2020Q4 us-gaap Interest Receivable
InterestReceivable
35317000 USD
CY2020Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
165960000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
16159000 USD
CY2020Q4 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
425954000 USD
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
18026000 USD
CY2020Q4 us-gaap Other Liabilities
OtherLiabilities
26177000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
6632029000 USD
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
42444031 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
39785398 shares
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
586946000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
23887000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
915310000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7547339000 USD
CY2020Q1 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
813000 USD
CY2020Q1 us-gaap Dividend Income Operating
DividendIncomeOperating
400000 USD
CY2020Q1 us-gaap Interest Income Federal Funds Sold
InterestIncomeFederalFundsSold
499000 USD
CY2020Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
76714000 USD
CY2020Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
17212000 USD
CY2020Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
4221000 USD
CY2020Q1 us-gaap Interest Expense
InterestExpense
21433000 USD
CY2020Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
55281000 USD
CY2020Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
16000000 USD
CY2020Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
39281000 USD
CY2021Q1 cnob Deposit Loan And Other Income
DepositLoanAndOtherIncome
1168000 USD
CY2020Q1 cnob Deposit Loan And Other Income
DepositLoanAndOtherIncome
1287000 USD
CY2021Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
1064000 USD
CY2020Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
967000 USD
CY2021Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
707000 USD
CY2020Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
393000 USD
CY2021Q1 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
USD
CY2021Q1 cnob Gain On Sale Of Branches
GainOnSaleOfBranches
-674000 USD
CY2020Q1 cnob Gain On Sale Of Branches
GainOnSaleOfBranches
USD
CY2021Q1 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
-187000 USD
CY2020Q1 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
178000 USD
CY2021Q1 us-gaap Noninterest Income
NoninterestIncome
3426000 USD
CY2020Q1 us-gaap Noninterest Income
NoninterestIncome
2854000 USD
CY2021Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
15632000 USD
CY2020Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
14593000 USD
CY2021Q1 us-gaap Occupancy Net
OccupancyNet
3404000 USD
CY2020Q1 us-gaap Occupancy Net
OccupancyNet
3471000 USD
CY2021Q1 cnob Federal Deposit Insurance Corporation Premium Expenses
FederalDepositInsuranceCorporationPremiumExpenses
935000 USD
CY2020Q1 cnob Federal Deposit Insurance Corporation Premium Expenses
FederalDepositInsuranceCorporationPremiumExpenses
856000 USD
CY2021Q1 us-gaap Professional Fees
ProfessionalFees
1956000 USD
CY2020Q1 us-gaap Professional Fees
ProfessionalFees
1574000 USD
CY2021Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
241000 USD
CY2020Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
304000 USD
CY2021Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
1536000 USD
CY2020Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
1473000 USD
CY2021Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
USD
CY2020Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
9494000 USD
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
507000 USD
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
652000 USD
CY2021Q1 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-67000 USD
CY2020Q1 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-30000 USD
CY2021Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
2341000 USD
CY2020Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
2671000 USD
CY2021Q1 us-gaap Noninterest Expense
NoninterestExpense
26485000 USD
CY2020Q1 us-gaap Noninterest Expense
NoninterestExpense
35058000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
43870000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
7077000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10871000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1047000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
32999000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
6030000 USD
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.83
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.82
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
32999000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
6030000 USD
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-5440000 USD
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
6252000 USD
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-1432000 USD
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
1691000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-4008000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
4561000 USD
CY2021Q1 cnob Other Comprehensive Income Loss Reclassification Adjustment For Net Gains Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForNetGainsBeforeTax
USD
CY2020Q1 cnob Other Comprehensive Income Loss Reclassification Adjustment For Net Gains Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForNetGainsBeforeTax
-29000 USD
CY2021Q1 cnob Other Comprehensive Income Loss Reclassification Adjustment For Net Gains Tax Effect
OtherComprehensiveIncomeLossReclassificationAdjustmentForNetGainsTaxEffect
USD
CY2020Q1 cnob Other Comprehensive Income Loss Reclassification Adjustment For Net Gains Tax Effect
OtherComprehensiveIncomeLossReclassificationAdjustmentForNetGainsTaxEffect
-6000 USD
CY2021Q1 cnob Other Comprehensive Income Loss Reclassification Adjustment For Net Gains Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForNetGainsNetOfTax
USD
CY2020Q1 cnob Other Comprehensive Income Loss Reclassification Adjustment For Net Gains Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForNetGainsNetOfTax
-23000 USD
CY2021Q1 cnob Unrealized Holding Gain On Cash Flow Hedge Before Tax
UnrealizedHoldingGainOnCashFlowHedgeBeforeTax
24000 USD
CY2020Q1 cnob Unrealized Holding Gain On Cash Flow Hedge Before Tax
UnrealizedHoldingGainOnCashFlowHedgeBeforeTax
-2749000 USD
CY2021Q1 cnob Other Comprehensive Income Unrealized Holding Gain Loss On Held To Maturity Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnHeldToMaturitySecuritiesArisingDuringPeriodTax
11000 USD
CY2020Q1 cnob Other Comprehensive Income Unrealized Holding Gain Loss On Held To Maturity Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnHeldToMaturitySecuritiesArisingDuringPeriodTax
-773000 USD
CY2021Q1 cnob Other Comprehensive Income Loss Held To Maturity Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossHeldToMaturitySecuritiesAdjustmentNetOfTax
13000 USD
CY2020Q1 cnob Other Comprehensive Income Loss Held To Maturity Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossHeldToMaturitySecuritiesAdjustmentNetOfTax
-1976000 USD
CY2021Q1 cnob Other Comprehensive Income Reclassification Adjustment For Net Gains Before Tax
OtherComprehensiveIncomeReclassificationAdjustmentForNetGainsBeforeTax
631000 USD
CY2020Q1 cnob Other Comprehensive Income Reclassification Adjustment For Net Gains Before Tax
OtherComprehensiveIncomeReclassificationAdjustmentForNetGainsBeforeTax
-7000 USD
CY2021Q1 cnob Other Comprehensive Income Reclassification Adjustment For Net Gains Tax Effect
OtherComprehensiveIncomeReclassificationAdjustmentForNetGainsTaxEffect
177000 USD
CY2020Q1 cnob Other Comprehensive Income Reclassification Adjustment For Net Gains Tax Effect
OtherComprehensiveIncomeReclassificationAdjustmentForNetGainsTaxEffect
-2000 USD
CY2021Q1 cnob Other Comprehensive Income Reclassification Adjustment For Net Gains Net Of Tax
OtherComprehensiveIncomeReclassificationAdjustmentForNetGainsNetOfTax
454000 USD
CY2020Q1 cnob Other Comprehensive Income Reclassification Adjustment For Net Gains Net Of Tax
OtherComprehensiveIncomeReclassificationAdjustmentForNetGainsNetOfTax
-5000 USD
CY2021Q1 cnob Reclassification Adjustment For Realized Losses Included In Net Income
ReclassificationAdjustmentForRealizedLossesIncludedInNetIncome
75000 USD
CY2020Q1 cnob Reclassification Adjustment For Realized Losses Included In Net Income
ReclassificationAdjustmentForRealizedLossesIncludedInNetIncome
75000 USD
CY2021Q1 cnob Reclassification Adjustment For Realized Losses Included In Net Income Tax Effect
ReclassificationAdjustmentForRealizedLossesIncludedInNetIncomeTaxEffect
20000 USD
CY2020Q1 cnob Reclassification Adjustment For Realized Losses Included In Net Income Tax Effect
ReclassificationAdjustmentForRealizedLossesIncludedInNetIncomeTaxEffect
21000 USD
CY2021Q1 cnob Reclassification Adjustment For Realized Losses Included In Net Income Net Of Tax
ReclassificationAdjustmentForRealizedLossesIncludedInNetIncomeNetOfTax
55000 USD
CY2020Q1 cnob Reclassification Adjustment For Realized Losses Included In Net Income Net Of Tax
ReclassificationAdjustmentForRealizedLossesIncludedInNetIncomeNetOfTax
54000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3486000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2611000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
29513000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8641000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
731190000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2611000 USD
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.090
CY2020Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
3987000 USD
CY2020Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
25413 shares
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
163000 USD
CY2020Q1 cnob Stock Issued During Period Shares Restricted Stock And Performance Units Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAndPerformanceUnitsAwardGross
20684 shares
CY2020Q1 cnob Stock Issued During Period Value Restricted Stock And Performance Units Award Gross
StockIssuedDuringPeriodValueRestrictedStockAndPerformanceUnitsAwardGross
USD
CY2020Q1 cnob Stock Issued During Period Shares Restricted Stock Unit
StockIssuedDuringPeriodSharesRestrictedStockUnit
16599 shares
CY2020Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
USD
CY2020Q1 cnob Net Performance Units Issued Shares
NetPerformanceUnitsIssuedShares
22402 shares
CY2020Q1 cnob Net Shares Issued In Satisfaction Of Performance Units Earned
NetSharesIssuedInSatisfactionOfPerformanceUnitsEarned
USD
CY2020Q1 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
-297000 USD
CY2020Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
54693 shares
CY2020Q1 us-gaap Treasury Stock Value Acquired Par Value Method
TreasuryStockValueAcquiredParValueMethod
911000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
118375000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
536000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
853710000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
915310000 USD
CY2021Q1 cnob New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption Quantification1
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification1
-2925000 USD
CY2020Q4 cnob Stockholders Equity Including Portion Attributable To Noncontrolling Interest Adjusted
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjusted
912385000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
32999000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3486000 USD
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.11
CY2021Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
3584000 USD
CY2021Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
5449 shares
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
45000 USD
CY2021Q1 cnob Stock Issued During Period Shares Restricted Stock And Performance Units Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAndPerformanceUnitsAwardGross
26769 shares
CY2021Q1 cnob Stock Issued During Period Value Restricted Stock And Performance Units Award Gross
StockIssuedDuringPeriodValueRestrictedStockAndPerformanceUnitsAwardGross
USD
CY2021Q1 cnob Stock Grants Shares
StockGrantsShares
446 shares
CY2021Q1 us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
USD
CY2021Q1 cnob Stock Issued During Period Shares Restricted Stock Unit
StockIssuedDuringPeriodSharesRestrictedStockUnit
14711 shares
CY2021Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
USD
CY2021Q1 cnob Net Performance Units Issued Shares
NetPerformanceUnitsIssuedShares
34458 shares
CY2021Q1 cnob Net Shares Issued In Satisfaction Of Performance Units Earned
NetSharesIssuedInSatisfactionOfPerformanceUnitsEarned
USD
CY2021Q1 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
-1283000 USD
CY2021Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
93629 shares
CY2021Q1 us-gaap Treasury Stock Value Acquired Par Value Method
TreasuryStockValueAcquiredParValueMethod
2411000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
972000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
935637000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
32999000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
6030000 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
880000 USD
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
949000 USD
CY2021Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
-5766000 USD
CY2020Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
16000000 USD
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
507000 USD
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
652000 USD
CY2021Q1 us-gaap Certain Loans Acquired In Transfer Accounted For As Debt Securities Accretable Yield Accretion
CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAccretableYieldAccretion
1406000 USD
CY2020Q1 us-gaap Certain Loans Acquired In Transfer Accounted For As Debt Securities Accretable Yield Accretion
CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAccretableYieldAccretion
1996000 USD
CY2021Q1 cnob Accretion On Bank Premises
AccretionOnBankPremises
23000 USD
CY2021Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
707000 USD
CY2020Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
393000 USD
CY2021Q1 us-gaap Payments For Origination And Purchases Of Loans Held For Sale
PaymentsForOriginationAndPurchasesOfLoansHeldForSale
23348000 USD
CY2021Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-22000 USD
CY2020Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
USD
CY2021Q1 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
1064000 USD
CY2020Q1 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
968000 USD
CY2021Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-1605000 USD
CY2020Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-1101000 USD
CY2021Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
76000 USD
CY2020Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
82000 USD
CY2020Q1 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
87391000 USD
CY2020Q1 cnob Accretion On Bank Premises
AccretionOnBankPremises
23000 USD
CY2021Q1 cnob Accretion On Deposits
AccretionOnDeposits
650000 USD
CY2020Q1 cnob Accretion On Deposits
AccretionOnDeposits
1503000 USD
CY2021Q1 cnob Amortization Accretion On Borrowings Net
AmortizationAccretionOnBorrowingsNet
17000 USD
CY2020Q1 cnob Amortization Accretion On Borrowings Net
AmortizationAccretionOnBorrowingsNet
-43000 USD
CY2021Q1 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
USD
CY2020Q1 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
29000 USD
CY2021Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-187000 USD
CY2020Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
178000 USD
CY2020Q1 us-gaap Payments For Origination And Purchases Of Loans Held For Sale
PaymentsForOriginationAndPurchasesOfLoansHeldForSale
5186000 USD
CY2021Q1 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
21856000 USD
CY2020Q1 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
17324000 USD
CY2021Q1 cnob Gain On Sale Of Branches
GainOnSaleOfBranches
-674000 USD
CY2020Q1 cnob Gain On Sale Of Branches
GainOnSaleOfBranches
USD
CY2021Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-68000 USD
CY2020Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
458000 USD
CY2021Q1 cnob Increase Decrease In Net Operating Leases
IncreaseDecreaseInNetOperatingLeases
-131000 USD
CY2020Q1 cnob Increase Decrease In Net Operating Leases
IncreaseDecreaseInNetOperatingLeases
-19000 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-47156000 USD
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-17366000 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
7589000 USD
CY2020Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-2869000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
80131000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
46461000 USD
CY2021Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
33305000 USD
CY2020Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
86731000 USD
CY2021Q1 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
USD
CY2020Q1 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
19624000 USD
CY2021Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
72193000 USD
CY2020Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
50294000 USD
CY2021Q1 us-gaap Increase Decrease Of Restricted Investments
IncreaseDecreaseOfRestrictedInvestments
-2616000 USD
CY2020Q1 us-gaap Increase Decrease Of Restricted Investments
IncreaseDecreaseOfRestrictedInvestments
8094000 USD
CY2021Q1 us-gaap Payments To Acquire Available For Sale Securities Equity
PaymentsToAcquireAvailableForSaleSecuritiesEquity
USD
CY2020Q1 us-gaap Payments To Acquire Available For Sale Securities Equity
PaymentsToAcquireAvailableForSaleSecuritiesEquity
2000000 USD
CY2021Q1 cnob Payments On Loans Held For Sale
PaymentsOnLoansHeldForSale
9000 USD
CY2020Q1 cnob Payments On Loans Held For Sale
PaymentsOnLoansHeldForSale
75000 USD
CY2021Q1 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
36553000 USD
CY2020Q1 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
130187000 USD
CY2021Q1 us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
USD
CY2020Q1 us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
25000000 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
67000 USD
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1728000 USD
CY2021Q1 us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
729000 USD
CY2020Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3576000 USD
CY2021Q1 us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
2411000 USD
CY2020Q1 us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
911000 USD
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
45000 USD
CY2020Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
163000 USD
CY2020Q1 us-gaap Proceeds From Federal Home Loan Bank Advances
ProceedsFromFederalHomeLoanBankAdvances
980000000 USD
CY2021Q1 us-gaap Payments For Federal Home Loan Bank Advances
PaymentsForFederalHomeLoanBankAdvances
66227000 USD
CY2020Q1 us-gaap Payments For Federal Home Loan Bank Advances
PaymentsForFederalHomeLoanBankAdvances
803222000 USD
CY2021Q1 cnob Decrease In Subordinated Debt
DecreaseInSubordinatedDebt
50000000 USD
CY2020Q1 cnob Decrease In Subordinated Debt
DecreaseInSubordinatedDebt
USD
CY2021Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3584000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-129417000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
130229000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-43664000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
81326000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
303756000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
201483000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
260092000 USD
CY2020Q1 us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
USD
CY2021Q1 us-gaap Proceeds From Sale Of Other Real Estate
ProceedsFromSaleOfOtherRealEstate
USD
CY2020Q1 us-gaap Proceeds From Sale Of Other Real Estate
ProceedsFromSaleOfOtherRealEstate
992000 USD
CY2021Q1 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
5622000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-95364000 USD
CY2021Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
-7240000 USD
CY2020Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
-42225000 USD
CY2021Q1 us-gaap Proceeds From Federal Home Loan Bank Advances
ProceedsFromFederalHomeLoanBankAdvances
USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
282809000 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
11690000 USD
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
24627000 USD
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4350000 USD
CY2020Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
7476000 USD
CY2021Q1 us-gaap Transfer Of Portfolio Loans And Leases To Held For Sale1
TransferOfPortfolioLoansAndLeasesToHeldForSale1
USD
CY2020Q1 us-gaap Transfer Of Portfolio Loans And Leases To Held For Sale1
TransferOfPortfolioLoansAndLeasesToHeldForSale1
10995000 USD
CY2021Q1 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
USD
CY2020Q1 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
949276000 USD
CY2021Q1 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
USD
CY2020Q1 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
852729000 USD
CY2021Q1 us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:6pt; margin-bottom:0pt; "> <span style="text-decoration:underline #000000; font-weight:bold; font-style:italic; ">Nature of Operations</span> </p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:6pt; text-indent:18pt; margin-bottom:0pt; ">ConnectOne Bancorp, Inc. (the “Parent Corporation”) is incorporated under the laws of the State of New Jersey and is a registered bank holding company. The Parent Corporation’s business currently consists of the operation of its wholly-owned subsidiary, ConnectOne Bank (the “Bank” and, collectively with the Parent Corporation and the Parent Corporation’s subsidiaries, the “Company”). The Bank’s subsidiaries include Union Investment Co. (a New Jersey investment company), Twin Bridge Investment Co. (a New Jersey investment company), ConnectOne Preferred Funding Corp. (a New Jersey real estate investment trust), Center Financial Group, LLC (a New Jersey financial services company), Center Advertising, Inc. (a New Jersey advertising company), Morris Property Company, LLC, (a New Jersey limited liability company), Volosin Holdings, LLC, (a New Jersey limited liability company), NJCB Spec-1, LLC (a New Jersey limited liability company), Port Jervis Holdings, LLC (a New Jersey limited liability company), BONJ Special Properties, LLC (a New Jersey limited liability company) and BoeFly, Inc. (a New Jersey online business lending marketplace). </p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:6pt; text-indent:18pt; margin-bottom:0pt; ">The Bank is a community-based, full-service New Jersey-chartered commercial bank that was founded in 2005. The Bank operates from its headquarters located at 301 Sylvan Avenue in the Borough of Englewood Cliffs, Bergen County, New Jersey and through its twenty-five other banking offices. Substantially all loans are secured with various types of collateral, including business assets, consumer assets and commercial/residential real estate. Each borrower’s ability to repay its loans is dependent on the conversion of assets, cash flows generated from the borrowers’ business, real estate rental and consumer wages.</p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:6pt; text-indent:18pt; margin-bottom:0pt; ">The preceding unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X, and, accordingly, do not include all of the information and footnotes required by GAAP for complete financial statements. However, in the opinion of management, all adjustments (consisting only of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2021 are not necessarily indicative of the results that may be expected for the full year ending December 31, 2021, or for any other interim period. The Company’s 2020 Annual Report on Form 10-K should be read in conjunction with these consolidated financial statements. </p>
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
39789000 shares
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
39516000 shares
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:6pt; margin-bottom:0pt; "> <span style="text-decoration:underline #000000; font-weight:bold; font-style:italic; ">Use of Estimates</span></p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:6pt; text-indent:18pt; margin-bottom:0pt; ">In preparing the consolidated financial statements, management has made estimates and assumptions that affect the reported amounts of assets and liabilities as of the dates of the consolidated statements of condition and that affect the results of operations for the periods presented. Actual results could differ significantly from those estimates. </p>
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.83
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.82
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
1304000 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Loss Purchased With Credit Deterioration Increase
FinancingReceivableAllowanceForCreditLossPurchasedWithCreditDeteriorationIncrease
USD
CY2021Q1 cnob Financing Receivable Allowance For Credit Losses Net
FinancingReceivableAllowanceForCreditLossesNet
1304000 USD
CY2021Q1 cnob Allowance Of Credit Losses Unfunded Credit Commitments
AllowanceOfCreditLossesUnfundedCreditCommitments
1621000 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
2925000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
32999000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
6030000 USD
CY2021Q1 cnob Dividends Paid On Earnings Allocated To Participating Securities
DividendsPaidOnEarningsAllocatedToParticipatingSecurities
-186000 USD
CY2020Q1 cnob Dividends Paid On Earnings Allocated To Participating Securities
DividendsPaidOnEarningsAllocatedToParticipatingSecurities
-27000 USD
CY2021Q1 cnob Net Income Loss Available To Common Stockholders
NetIncomeLossAvailableToCommonStockholders
32813000 USD
CY2020Q1 cnob Net Income Loss Available To Common Stockholders
NetIncomeLossAvailableToCommonStockholders
6003000 USD
CY2021Q1 cnob Weighted Average Common Shares Outstanding Including Participating Securities
WeightedAverageCommonSharesOutstandingIncludingParticipatingSecurities
39738000 shares
CY2020Q1 cnob Weighted Average Common Shares Outstanding Including Participating Securities
WeightedAverageCommonSharesOutstandingIncludingParticipatingSecurities
39559000 shares
CY2021Q1 cnob Weighted Average Participating Securities
WeightedAverageParticipatingSecurities
-181000 shares
CY2020Q1 cnob Weighted Average Participating Securities
WeightedAverageParticipatingSecurities
-135000 shares
CY2021Q1 cnob Weighted Average Common Shares Outstanding
WeightedAverageCommonSharesOutstanding
39557000 shares
CY2020Q1 cnob Weighted Average Common Shares Outstanding
WeightedAverageCommonSharesOutstanding
39424000 shares
CY2021Q1 cnob Incremental Shares From Assumed Conversions Of Options Performance Units And Restricted Shares
IncrementalSharesFromAssumedConversionsOfOptionsPerformanceUnitsAndRestrictedShares
232000 shares
CY2020Q1 cnob Incremental Shares From Assumed Conversions Of Options Performance Units And Restricted Shares
IncrementalSharesFromAssumedConversionsOfOptionsPerformanceUnitsAndRestrictedShares
92000 shares
CY2021Q1 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
436834000 USD
CY2021Q1 cnob Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
7959000 USD
CY2021Q1 cnob Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
2770000 USD
CY2021Q1 us-gaap Available For Sale Securities
AvailableForSaleSecurities
442023000 USD
CY2020Q1 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
29000 USD
CY2021Q1 us-gaap Loss On Sale Of Investments
LossOnSaleOfInvestments
USD
CY2020Q1 us-gaap Loss On Sale Of Investments
LossOnSaleOfInvestments
USD
CY2021Q1 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
USD
CY2020Q1 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
29000 USD
CY2021Q1 cnob Tax Provision On Gain On Sale Of Investments
TaxProvisionOnGainOnSaleOfInvestments
USD
CY2020Q1 cnob Tax Provision On Gain On Sale Of Investments
TaxProvisionOnGainOnSaleOfInvestments
6000 USD
CY2021Q1 cnob Available For Sale Securities Allowance For Investment Credit Losses
AvailableForSaleSecuritiesAllowanceForInvestmentCreditLosses
USD
CY2020Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
477326000 USD
CY2020Q4 cnob Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
11015000 USD
CY2020Q4 cnob Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
386000 USD
CY2020Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
487955000 USD
CY2021Q1 us-gaap Debt Securities Available For Sale Restricted
DebtSecuritiesAvailableForSaleRestricted
112200000 USD
CY2020Q4 us-gaap Debt Securities Available For Sale Restricted
DebtSecuritiesAvailableForSaleRestricted
107600000 USD
CY2021Q1 cnob Description Of Holding Securities
DescriptionOfHoldingSecurities
there were no holdings of securities of any one issuer, other than the U.S. Government and its agencies, in an amount greater than 10% of stockholders’ equity.
CY2020 cnob Description Of Holding Securities
DescriptionOfHoldingSecurities
there were no holdings of securities of any one issuer, other than the U.S. Government and its agencies, in an amount greater than 10% of stockholders’ equity.
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
5898000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
5929000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
16369000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
16625000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
14172000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
14527000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
152831000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
155897000 USD
CY2021Q1 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
436834000 USD
CY2021Q1 us-gaap Available For Sale Securities
AvailableForSaleSecurities
442023000 USD
CY2021Q1 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
USD
CY2020Q1 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
19624000 USD
CY2021Q1 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
USD
CY2020Q1 us-gaap Derivative Liability Notional Amount
DerivativeLiabilityNotionalAmount
25000000.0 USD
CY2021Q1 us-gaap Derivative Asset Notional Amount
DerivativeAssetNotionalAmount
175000000 USD
CY2021Q1 cnob Gain Loss On Sale Of Investments Net Of Tax
GainLossOnSaleOfInvestmentsNetOfTax
USD
CY2020Q1 cnob Gain Loss On Sale Of Investments Net Of Tax
GainLossOnSaleOfInvestmentsNetOfTax
23000 USD
CY2021Q1 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue
176608000 USD
CY2021Q1 cnob Held To Maturity Securities Accumulated Unrecognized Holding Loss Gross
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLossGross
-2770000 USD
CY2021Q1 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
175699000 USD
CY2021Q1 cnob Held To Maturity Securities Continuous Unrealized Loss Position Less Than Twelve Months Unrealized Losses
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsUnrealizedLosses
-2760000 USD
CY2021Q1 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
909000 USD
CY2021Q1 cnob Heldtomaturity Securities Continuous Unrealized Loss Position Twelve Months Or Longer Accumulated Loss
HeldtomaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerAccumulatedLoss
-10000 USD
CY2020Q4 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue
40838000 USD
CY2020Q4 cnob Held To Maturity Securities Accumulated Unrecognized Holding Loss Gross
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLossGross
-386000 USD
CY2020Q4 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
38365000 USD
CY2020Q4 cnob Held To Maturity Securities Continuous Unrealized Loss Position Less Than Twelve Months Unrealized Losses
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsUnrealizedLosses
-345000 USD
CY2020Q4 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
2473000 USD
CY2020Q4 cnob Heldtomaturity Securities Continuous Unrealized Loss Position Twelve Months Or Longer Accumulated Loss
HeldtomaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerAccumulatedLoss
-41000 USD
CY2021Q1 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
1600000 USD
CY2020Q4 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
1700000 USD
CY2020Q4 us-gaap Derivative Asset Notional Amount
DerivativeAssetNotionalAmount
175000000 USD
CY2020Q1 us-gaap Derivative Asset Notional Amount
DerivativeAssetNotionalAmount
200000000 USD
CY2021Q1 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
-1464000 USD
CY2020Q4 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
-2119000 USD
CY2020Q1 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
-3029000 USD
CY2021Q1 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
6295508000 USD
CY2020Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
6247681000 USD
CY2021Q1 cnob Paycheck Protection Program Loans
PaycheckProtectionProgramLoans
522300000 USD
CY2020Q4 cnob Paycheck Protection Program Loans
PaycheckProtectionProgramLoans
397500000 USD
CY2021Q1 us-gaap Loans Pledged As Collateral
LoansPledgedAsCollateral
2600000000 USD
CY2020Q4 us-gaap Loans Pledged As Collateral
LoansPledgedAsCollateral
2700000000 USD
CY2020Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
61696000 USD
CY2020Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
6247681000 USD
CY2021Q1 us-gaap Securities Loaned Fair Value Of Collateral
SecuritiesLoanedFairValueOfCollateral
92368000 USD
CY2020Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
54092000 USD
CY2020Q4 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
55914000 USD
CY2020Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
26458000 USD
CY2020Q4 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
71844000 USD
CY2020Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
14314000 USD
CY2020Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
80550000 USD
CY2020Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
127758000 USD
CY2020Q1 us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
72878000 USD
CY2020Q1 us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Cash Basis Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeCashBasisMethod
263000 USD
CY2020Q1 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
6725000 USD
CY2020Q1 us-gaap Impaired Financing Receivable With Related Allowance Interest Income Cash Basis Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeCashBasisMethod
3000 USD
CY2020Q1 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
79603000 USD
CY2020Q1 us-gaap Impaired Financing Receivable Interest Income Cash Basis Method
ImpairedFinancingReceivableInterestIncomeCashBasisMethod
266000 USD
CY2021Q1 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
60940000 USD
CY2021Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
95187000 USD
CY2021Q1 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
6295508000 USD
CY2020Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
61696000 USD
CY2020Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
98000000 USD
CY2020Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
6247681000 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
18014000 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
57347000 USD
CY2021Q1 cnob Allowance For Loan And Lease Losses Acquired With Deteriorated Credit Quality
AllowanceForLoanAndLeaseLossesAcquiredWithDeterioratedCreditQuality
5207000 USD
CY2021Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
80568000 USD
CY2021Q1 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
81280000 USD
CY2021Q1 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
6197084000 USD
CY2021Q1 cnob Loans Receivables Acquired With Deteriorated Credit Quality
LoansReceivablesAcquiredWithDeterioratedCreditQuality
17144000 USD
CY2021Q1 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
6295508000 USD
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
14314000 USD
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
59072000 USD
CY2020Q4 cnob Allowance For Loan And Lease Losses Acquired Portfolio
AllowanceForLoanAndLeaseLossesAcquiredPortfolio
5840000 USD
CY2020Q4 cnob Allowance For Loan And Lease Losses Acquired With Deteriorated Credit Quality
AllowanceForLoanAndLeaseLossesAcquiredWithDeterioratedCreditQuality
USD
CY2020Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
79226000 USD
CY2020Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
80550000 USD
CY2020Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
5192274000 USD
CY2020Q4 cnob Loans Receivable Acquired Portfolio
LoansReceivableAcquiredPortfolio
961340000 USD
CY2020Q4 cnob Loans Receivables Acquired With Deteriorated Credit Quality
LoansReceivablesAcquiredWithDeterioratedCreditQuality
13517000 USD
CY2020Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
6247681000 USD
CY2020Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
79226000 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
6557000 USD
CY2020Q4 cnob Loans And Leases Receivable Allowance Adjustment
LoansAndLeasesReceivableAllowanceAdjustment
85783000 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
61000 USD
CY2021Q1 cnob Reversal Of Provision For Credit Losses Loans
ReversalOfProvisionForCreditLossesLoans
-5276000 USD
CY2021Q1 cnob Allowance For Loan Losses Included In Unallocated
AllowanceForLoanLossesIncludedInUnallocated
6600000 USD
CY2021Q1 cnob Allowance For Loan Losses Included In Unallocated
AllowanceForLoanLossesIncludedInUnallocated
5300000 USD
CY2019Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
38293000 USD
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
127000 USD
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
3000 USD
CY2020Q1 cnob Reversal Of Provision For Credit Losses Loans
ReversalOfProvisionForCreditLossesLoans
16000000 USD
CY2020Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
54169000 USD
CY2021Q1 cnob Non Accrual Contractual Due
NonAccrualContractualDue
P90D
CY2021Q1 us-gaap Troubled Debt Restructuring Debtor Current Period Gain Loss On Transfer Of Assets Net Of Tax
TroubledDebtRestructuringDebtorCurrentPeriodGainLossOnTransferOfAssetsNetOfTax
53000000.0 USD
CY2021Q1 us-gaap Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans
LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans
27500000 USD
CY2021Q1 cnob Loans Performing Under Restructured Terms
LoansPerformingUnderRestructuredTerms
25500000 USD
CY2020 us-gaap Troubled Debt Restructuring Debtor Current Period Gain Loss On Transfer Of Assets Net Of Tax
TroubledDebtRestructuringDebtorCurrentPeriodGainLossOnTransferOfAssetsNetOfTax
49400000 USD
CY2020 us-gaap Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans
LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans
25700000 USD
CY2020 cnob Loans Performing Under Restructured Terms
LoansPerformingUnderRestructuredTerms
23700000 USD
CY2021Q1 cnob Specific Allowance Of Troubled Debt Restructuring
SpecificAllowanceOfTroubledDebtRestructuring
10000000.0 USD
CY2020Q1 cnob Specific Allowance Of Troubled Debt Restructuring
SpecificAllowanceOfTroubledDebtRestructuring
47000 USD
CY2021Q1 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
3 Integer
CY2021Q1 us-gaap Financing Receivable Modifications Pre Modification Recorded Investment2
FinancingReceivableModificationsPreModificationRecordedInvestment2
3654000 USD
CY2021Q1 us-gaap Financing Receivable Modifications Post Modification Recorded Investment2
FinancingReceivableModificationsPostModificationRecordedInvestment2
3654000 USD
CY2020Q4 cnob Number Of Deferred Loans
NumberOfDeferredLoans
113 Loans
CY2020Q4 cnob Deferred Loan
DeferredLoan
207100000 USD
CY2021Q1 cnob Number Of Deferred Loans
NumberOfDeferredLoans
102 Loans
CY2021Q1 cnob Deferred Loan
DeferredLoan
204203000 USD
CY2020Q4 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
USD
CY2021Q1 cnob Day One Effect Of Cecl
DayOneEffectOfCecl
2833000 USD
CY2021Q1 us-gaap Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal
OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal
-490000 USD
CY2021Q1 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
2343000 USD
CY2021Q1 us-gaap Provision For Other Losses
ProvisionForOtherLosses
-5276000 USD
CY2021Q1 us-gaap Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal
OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal
-490000 USD
CY2021Q1 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
-5766000 USD
CY2020Q4 us-gaap Restricted Investments
RestrictedInvestments
25099000 USD
CY2020Q4 us-gaap Restricted Investments At Fair Value
RestrictedInvestmentsAtFairValue
USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
260092000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
260092000 USD
CY2021Q1 cnob Available For Sale Securities Carrying Value
AvailableForSaleSecuritiesCarryingValue
442023000 USD
CY2021Q1 us-gaap Available For Sale Securities
AvailableForSaleSecurities
442023000 USD
CY2021Q1 us-gaap Restricted Investments
RestrictedInvestments
22483000 USD
CY2021Q1 us-gaap Restricted Investments At Fair Value
RestrictedInvestmentsAtFairValue
USD
CY2021Q1 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
13200000 USD
CY2021Q1 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
13200000 USD
CY2021Q1 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
6196623000 USD
CY2021Q1 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
6267519000 USD
CY2021Q1 us-gaap Interest Receivable
InterestReceivable
35249000 USD
CY2021Q1 us-gaap Receivables Fair Value Disclosure
ReceivablesFairValueDisclosure
35249000 USD
CY2021Q1 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
1384961000 USD
CY2021Q1 cnob Non Interest Bearing Deposits Fair Value Disclosure
NonInterestBearingDepositsFairValueDisclosure
1384961000 USD
CY2021Q1 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
4566373000 USD
CY2021Q1 cnob Interest Bearing Deposits Fair Value Disclosure
InterestBearingDepositsFairValueDisclosure
4573673000 USD
CY2021Q1 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
359710000 USD
CY2021Q1 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
362497000 USD
CY2021Q1 us-gaap Other Borrowings
OtherBorrowings
152724000 USD
CY2021Q1 us-gaap Fair Value Liabilities Measured On Recurring Basis Subordinated Debt Obligations
FairValueLiabilitiesMeasuredOnRecurringBasisSubordinatedDebtObligations
163868000 USD
CY2021Q1 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
1464000 USD
CY2021Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
1464000 USD
CY2021Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
3598000 USD
CY2021Q1 us-gaap Accrued Liabilities Fair Value Disclosure
AccruedLiabilitiesFairValueDisclosure
3598000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
303756000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
303756000 USD
CY2020Q4 cnob Available For Sale Securities Carrying Value
AvailableForSaleSecuritiesCarryingValue
487955000 USD
CY2020Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
487955000 USD
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
8.34
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
32564 shares
CY2020Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
13387000 USD
CY2020Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
13387000 USD
CY2020Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
6157081000 USD
CY2020Q4 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
6244037000 USD
CY2020Q4 us-gaap Interest Receivable
InterestReceivable
35317000 USD
CY2020Q4 us-gaap Receivables Fair Value Disclosure
ReceivablesFairValueDisclosure
35317000 USD
CY2020Q4 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
1339108000 USD
CY2020Q4 cnob Non Interest Bearing Deposits Fair Value Disclosure
NonInterestBearingDepositsFairValueDisclosure
1339108000 USD
CY2020Q4 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
4620116000 USD
CY2020Q4 cnob Interest Bearing Deposits Fair Value Disclosure
InterestBearingDepositsFairValueDisclosure
4633961000 USD
CY2020Q4 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
425954000 USD
CY2020Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
429671000 USD
CY2020Q4 us-gaap Other Borrowings
OtherBorrowings
202648000 USD
CY2020Q4 us-gaap Fair Value Liabilities Measured On Recurring Basis Subordinated Debt Obligations
FairValueLiabilitiesMeasuredOnRecurringBasisSubordinatedDebtObligations
214113000 USD
CY2020Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
2119000 USD
CY2020Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
2119000 USD
CY2020Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
3687000 USD
CY2020Q4 us-gaap Accrued Liabilities Fair Value Disclosure
AccruedLiabilitiesFairValueDisclosure
3687000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
3851000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
7859000 USD
CY2021Q1 cnob Accumulated Other Comprehensive Income Loss Cash Flow Hedge
AccumulatedOtherComprehensiveIncomeLossCashFlowHedge
1053000 USD
CY2020Q4 cnob Accumulated Other Comprehensive Income Loss Cash Flow Hedge
AccumulatedOtherComprehensiveIncomeLossCashFlowHedge
1520000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
3487000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
3542000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-689000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2797000 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P3Y
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
38013 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.03
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2021Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
5449 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.15
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y2M15D
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
527672000 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
32564 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
9.15
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y2M15D
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
527672000 USD
CY2021Q1 us-gaap Federal Home Loan Bank Advances Maturities Summary Average Interest Rate Two To Three Years From Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryAverageInterestRateTwoToThreeYearsFromBalanceSheetDate
0.0292 pure
CY2020Q4 us-gaap Federal Home Loan Bank Advances Maturities Summary Due From Two To Three Years Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueFromTwoToThreeYearsOfBalanceSheetDate
50000000 USD
CY2020Q4 us-gaap Federal Home Loan Bank Advances Maturities Summary Average Interest Rate Two To Three Years From Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryAverageInterestRateTwoToThreeYearsFromBalanceSheetDate
0.0184 pure
CY2021Q1 us-gaap Federal Home Loan Bank Advances Maturities Summary Due From Three To Four Years Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueFromThreeToFourYearsOfBalanceSheetDate
USD
CY2020Q4 us-gaap Federal Home Loan Bank Advances Maturities Summary Due From Three To Four Years Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueFromThreeToFourYearsOfBalanceSheetDate
USD
CY2020Q4 us-gaap Federal Home Loan Bank Advances Maturities Summary Average Interest Rate Three To Four Years From Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryAverageInterestRateThreeToFourYearsFromBalanceSheetDate
pure
CY2020Q4 cnob Total Federal Home Loan Bank Advances Before Fair Value Discount Premium
TotalFederalHomeLoanBankAdvancesBeforeFairValueDiscountPremium
426038000 USD
CY2020Q4 cnob Federal Home Loan Bank Advances Average Interest Rate
FederalHomeLoanBankAdvancesAverageInterestRate
0.0107 pure
CY2021Q1 cnob Federal Home Loan Bank Advances Discount Premium
FederalHomeLoanBankAdvancesDiscountPremium
-101000 USD
CY2020Q4 cnob Federal Home Loan Bank Advances Discount Premium
FederalHomeLoanBankAdvancesDiscountPremium
-84000 USD
CY2021Q1 cnob Total Federal Home Loan Bank Advances
TotalFederalHomeLoanBankAdvances
359710000 USD
CY2020Q4 cnob Total Federal Home Loan Bank Advances
TotalFederalHomeLoanBankAdvances
425954000 USD
CY2021Q1 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
USD
CY2020Q1 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
USD
CY2021Q1 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
71000 USD
CY2020Q1 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
91000 USD
CY2021Q1 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
213000 USD
CY2020Q1 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
196000 USD
CY2021Q1 cnob Defined Benefit Plan Amortization And Deferral Net
DefinedBenefitPlanAmortizationAndDeferralNet
75000 USD
CY2020Q1 cnob Defined Benefit Plan Amortization And Deferral Net
DefinedBenefitPlanAmortizationAndDeferralNet
75000 USD
CY2021Q1 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
-67000 USD
CY2020Q1 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
-30000 USD
CY2021Q1 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
359710000 USD
CY2021Q1 cnob Federal Home Loan Bank Advances Average Interest Rate
FederalHomeLoanBankAdvancesAverageInterestRate
0.0111 pure
CY2020Q4 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
425954000 USD
CY2020Q4 cnob Federal Home Loan Bank Advances Average Interest Rate
FederalHomeLoanBankAdvancesAverageInterestRate
0.0107 pure
CY2021Q1 us-gaap Federal Home Loan Bank Advances Maturities Summary Due Within One Year Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueWithinOneYearOfBalanceSheetDate
297381000 USD
CY2021Q1 us-gaap Federal Home Loan Bank Advances Maturities Summary Average Interest Rate Of Amounts Due Within One Year Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryAverageInterestRateOfAmountsDueWithinOneYearOfBalanceSheetDate
0.0093 pure
CY2020Q4 us-gaap Federal Home Loan Bank Advances Maturities Summary Due Within One Year Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueWithinOneYearOfBalanceSheetDate
297570000 USD
CY2020Q4 us-gaap Federal Home Loan Bank Advances Maturities Summary Average Interest Rate Of Amounts Due Within One Year Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryAverageInterestRateOfAmountsDueWithinOneYearOfBalanceSheetDate
0.0084 pure
CY2021Q1 us-gaap Federal Home Loan Bank Advances Maturities Summary Due From One To Two Years Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueFromOneToTwoYearsOfBalanceSheetDate
34621000 USD
CY2021Q1 us-gaap Federal Home Loan Bank Advances Maturities Summary Average Interest Rate One To Two Years From Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryAverageInterestRateOneToTwoYearsFromBalanceSheetDate
0.0124 pure
CY2020Q4 us-gaap Federal Home Loan Bank Advances Maturities Summary Due From One To Two Years Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueFromOneToTwoYearsOfBalanceSheetDate
75644000 USD
CY2020Q4 us-gaap Federal Home Loan Bank Advances Maturities Summary Average Interest Rate One To Two Years From Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryAverageInterestRateOneToTwoYearsFromBalanceSheetDate
0.0142 pure
CY2021Q1 us-gaap Federal Home Loan Bank Advances Maturities Summary Due From Two To Three Years Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueFromTwoToThreeYearsOfBalanceSheetDate
25000000 USD
CY2021Q1 us-gaap Federal Home Loan Bank Advances Maturities Summary Due From Four To Five Years Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueFromFourToFiveYearsOfBalanceSheetDate
USD
CY2020Q4 us-gaap Federal Home Loan Bank Advances Maturities Summary Due From Four To Five Years Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueFromFourToFiveYearsOfBalanceSheetDate
USD
CY2020Q4 us-gaap Federal Home Loan Bank Advances Maturities Summary Average Interest Rate Four To Five Years From Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryAverageInterestRateFourToFiveYearsFromBalanceSheetDate
pure
CY2021Q1 us-gaap Federal Home Loan Bank Advances Maturities Summary Due After Five Years Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueAfterFiveYearsOfBalanceSheetDate
2809000 USD
CY2021Q1 us-gaap Federal Home Loan Bank Advances Maturities Summary Average Interest Rate After Five Years From Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryAverageInterestRateAfterFiveYearsFromBalanceSheetDate
0.0241 pure
CY2020Q4 us-gaap Federal Home Loan Bank Advances Maturities Summary Due After Five Years Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueAfterFiveYearsOfBalanceSheetDate
2824000 USD
CY2020Q4 us-gaap Federal Home Loan Bank Advances Maturities Summary Average Interest Rate After Five Years From Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryAverageInterestRateAfterFiveYearsFromBalanceSheetDate
0.0242 pure
CY2021Q1 cnob Total Federal Home Loan Bank Advances Before Fair Value Discount Premium
TotalFederalHomeLoanBankAdvancesBeforeFairValueDiscountPremium
359811000 USD
CY2021Q1 cnob Federal Home Loan Bank Advances Average Interest Rate
FederalHomeLoanBankAdvancesAverageInterestRate
0.0111 pure
CY2021Q1 cnob Federal Home Loan Bank Advances Value Of Collateral
FederalHomeLoanBankAdvancesValueOfCollateral
1900000000 USD
CY2021Q1 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
1100000000 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Trust Preferred Securities
ProceedsFromIssuanceOfTrustPreferredSecurities
5000000000 USD
CY2020 us-gaap Proceeds From Issuance Of Trust Preferred Securities
ProceedsFromIssuanceOfTrustPreferredSecurities
5000000000 USD
CY2021Q1 cnob Liquidation Value Per Capital Share Description
LiquidationValuePerCapitalShareDescription
$1,000 per Capital Security
CY2020 cnob Liquidation Value Per Capital Share Description
LiquidationValuePerCapitalShareDescription
$1,000 per Capital Security
CY2021Q1 cnob Rate Added To Libor
RateAddedToLibor
Floating 3-month LIBOR + 285 Basis Points
CY2020 cnob Rate Added To Libor
RateAddedToLibor
Floating 3-month LIBOR + 285 Basis Points

Files In Submission

Name View Source Status
0001206774-21-001404-index-headers.html Edgar Link pending
0001206774-21-001404-index.html Edgar Link pending
0001206774-21-001404.txt Edgar Link pending
0001206774-21-001404-xbrl.zip Edgar Link pending
cnob-20210331.xsd Edgar Link pending
cnob-20210331_cal.xml Edgar Link unprocessable
cnob-20210331_def.xml Edgar Link unprocessable
cnob-20210331_lab.xml Edgar Link unprocessable
cnob-20210331_pre.xml Edgar Link unprocessable
cnob-large.jpg Edgar Link pending
cnob3904631-10q.htm Edgar Link pending
cnob3904631-10q_htm.xml Edgar Link completed
cnob3904631-ex311.htm Edgar Link pending
cnob3904631-ex312.htm Edgar Link pending
cnob3904631-ex321.htm Edgar Link pending
cnob3904631-ex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending